Order Article Reprints

Hata S, Okamura T, Kobayashi A, Bamba R, Miyoshi T, Nakajima H, Kitagawa N, Hashimoto Y, Majima S, Senmaru T, et al. Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice. Nutrients. 2022; 14(17):3531. https://doi.org/10.3390/nu14173531

Hata, Shinnosuke, Takuro Okamura, Ayaka Kobayashi, Ryo Bamba, Tomoki Miyoshi, Hanako Nakajima, Nobuko Kitagawa, Yoshitaka Hashimoto, Saori Majima, Takafumi Senmaru, and et al. 2022. "Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice" Nutrients 14, no. 17: 3531. https://doi.org/10.3390/nu14173531

Hata, S., Okamura, T., Kobayashi, A., Bamba, R., Miyoshi, T., Nakajima, H., Kitagawa, N., Hashimoto, Y., Majima, S., Senmaru, T., Okada, H., Ushigome, E., Nakanishi, N., Takakuwa, H., Sasano, R., Hamaguchi, M., & Fukui, M. (2022). Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice. Nutrients, 14(17), 3531. https://doi.org/10.3390/nu14173531